Insights

article

Shifting the starting line: regulatory changes to impact Australian pharma patent disputes

article

COVID-19: when do private patent rights give way to the public interest?

article

Full Federal Court decision represents useful guidance on additional damages for patent infringement

article

Protecting your IP assets: key issues for tech start-ups and emerging companies

article

A lost opportunity? Full Federal Court holds that mere ‘abstract ideas’ using ‘generic computer technology’ lack patentability

article

A turning of the tide: interlocutory injunctions in Australian pharma patent cases

article

Key IP enforcement tool likely to be abolished: time to act now

article

Motorola v Hytera: standard essential patents to be considered by Federal Court

article

Change in the air for IP laws in Australia: 5 key takeaways